Compugen Ltd. (CGEN)
NASDAQ·Healthcare·Biotechnology
$2.73
-6.51%
Mkt Cap $201.10M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+46.5%
Consensus $4.00 vs current $2.73
NASDAQ·Healthcare·Biotechnology
$2.73
-6.51%
Mkt Cap $201.10M
No recent rating data.
Price Target (4 analysts)
$4.00
Range $4.00 – $4.00
+46.5%
Consensus $4.00 vs current $2.73